As the pharmaceutical industry becomes increasingly focused on biologics, having a robust purification process is key to delivering high-quality drug products.
The manufacturing of biologics is complex and depends on multiple factors such as the type of molecule and their impurities. Since each molecule is unique, designing a purification strategy is important for the project's success.
Agarose Bead Technologies (ABT) owns a proprietary agarose-based bead technology that develops a wide range of agarose resins that are used in chromatographic purification of biomolecules including proteins, antibodies, enzymes, and oligonucleotides, among others.
ABT is extremely committed to supporting the production of life-saving biotherapeutics and diagnostic tools. For this reason, relying on strategic partners like Repligen, a leader in prepacked columns, is crucial for our customers in the bioprocess industry. Recently, our General Manager, Carolina Egea, visited the impressive new Repligen manufacturing plant in Europe, located in Breda (The Netherlands), and took a nice photo next to one of the largest columns in the OPUS line, the OPUS 80R column, packed with 150L of our DEAE Rapid Run Ion Exchange resin.